GHK-Cu is typically associated with collagen signaling, skin remodeling, and tissue regeneration, while BPC-157 is more often discussed in relation to tendon, ligament, muscle, gut, and musculoskeletal recovery models
Providers should transition to emerging weight loss peptides when a patient experiences intractable side effects (like severe nausea or gastroparesis), when they hit a hard weight loss plateau despite dietary compliance, or when the primary clinical obstacle is documented cellular metabolic resistance rather than hyperphagia (overeating)
Generally, researchers restart the titration schedule with retatrutide regardless of their previous dose, though some experienced practitioners adjust based on their GLP-1 tolerance history
Oral forms (capsules, sprays, or drops) are easier to administer
10.1021/acs.jctc.1c00752
Saxenda is a weight loss injection that helps adults with issues surrounding obesity